Amboy Street Ventures invests $1m in Aunt Flow

Amboy Street Ventures (ASV) is excited to announce its latest $1m investment in Aunt Flow to support the company’s plans to make free, 100% organic cotton period products available in every restroom, changing the world one cycle at a time.

Aunt Flow is committed to ensuring everyone has access to menstrual products by placing free menstrual products in public and corporate bathrooms. It already has placed patented free-vend innovative dispensers with 100% organic cotton period products in 23,000 bathrooms, with partners including Netflix and Google’s offices; Princeton and Penn State University, among others; and is in more than 200 Apple retail stores.

With the funding, Aunt Flow will be able to expand its customer base nationally, grow advocacy efforts, donate more than a million products to grassroots partners and introduce new products and more sustainable packaging.

Claire Coder, Chief Estrogen Officer (CEO) of Aunt Flow, said, “How people think about periods is changing. We are proud to be at the forefront of the menstrual movement, with a singular focus on making period products accessible to everyone. If toilet paper is offered for free in public restrooms, tampons and pads should be too.”

Carli Sapir, Founding Partner of Amboy Street Ventures, said, “It’s time to improve the quality and accessibility of menstrual products. It is a pleasure to see brands like Aunt Flow make sustainable, high quality menstrual products ubiquitous. While the D2C menstrual product space is crowded, Aunt Flow has a unique B2B strategy which allows it to break through the crowd. Not only is innovation in this space a huge economic opportunity, it is also creating much needed progress in the underserved women’s health space.”

Aunt Flow is the latest brand to join ASV’s growing portfolio of brands at the forefront of social change in the industry including Contraline, a medical device company devoted to providing men and couples with long-lasting, safe and effective male contraception; Dipsea, an audio erotica platform where sexual wellness meets storytelling; Gennev, the digital health platform for women in menopause and Dame Products, a leading female-focused sexual wellness brand.

Continue Reading

Top 10 Deals of 2024: Hologic Acquires Endomag for $310M

This week we highlight a second acquisition by the active women’s health acquirer, Hologic, in a large market segment of women’s health: breast cancer.

Top 10 Deals of 2024: IVI RMA Acquires Eugin Group for $535M

This week we explore one of a growing number of consolidation plays in the IVF space, IVI RMA’s acquisition of Boston IVF and TRIO. This trend suggests there is value in 4-wall IVF clinics, reflecting an interesting area of investment.

Top 10 Deals of 2024: Hologic Acquires Uterine Fibroid Treatment Company for $350M

This blog assesses a recent women’s health deal that expands treatment options for uterine fibroids and abnormal uterine bleeding. These indications are infrequently discussed and therefore unfamiliar to many, yet impact a significant number of women, especially those in perimenopause.

Top 10 Deals of 2024: Hologic Acquires Endomag for $310M

This week we highlight a second acquisition by the active women’s health acquirer, Hologic, in a large market segment of women’s health: breast cancer.

Top 10 Deals of 2024: IVI RMA Acquires Eugin Group for $535M

This week we explore one of a growing number of consolidation plays in the IVF space, IVI RMA’s acquisition of Boston IVF and TRIO. This trend suggests there is value in 4-wall IVF clinics, reflecting an interesting area of investment.

Fast track our industry.
Get in touch today.